U.S. dog importations during the COVID-19 pandemic: Do we have an erupting problem?

PLoS One. 2021 Sep 7;16(9):e0254287. doi: 10.1371/journal.pone.0254287. eCollection 2021.

Abstract

Dog importation data from 2018-2020 were evaluated to ascertain whether the dog importation patterns in the United States changed during the COVID-19 pandemic, specifically with regard to denial of entry. Dog denial of entry reports from January 1, 2018, to December 31, 2020, stored within the Centers for Disease Control and Prevention (CDC) Quarantine Activity Reporting System (QARS), were reviewed. Basic descriptive statistics were used to analyze the data. Reason for denial, country of origin, and month of importation were all examined to determine which countries of origin resulted in the largest number of denials, and whether there was a seasonal change in importations during the COVID-19 pandemic (2020), compared to previous years (2018 and 2019). During 2020, CDC denied entry to 458 dogs. This represents a 52% increase in dogs denied entry compared to the averages in 2018 and 2019. Dogs were primarily denied entry for falsified rabies vaccination certificates (56%). Three countries exported 74% of all dogs denied entry into the United States, suggesting that targeted interventions may be needed for certain countries. Increased attempts to import inadequately vaccinated dogs from countries with canine rabies in 2020 may have been due to the increased demand for domestic pets during the COVID-19 pandemic. Educational messaging should highlight the risk of rabies and the importance of making informed pet purchases from foreign entities to protect pet owners, their families, and the public.

MeSH terms

  • Animals
  • COVID-19 / epidemiology*
  • Centers for Disease Control and Prevention, U.S.
  • Dog Diseases / immunology
  • Dog Diseases / prevention & control*
  • Dogs
  • Humans
  • Pandemics / prevention & control
  • Quarantine
  • Rabies / epidemiology*
  • Rabies / immunology
  • Rabies / prevention & control*
  • Rabies Vaccines / immunology
  • SARS-CoV-2 / pathogenicity
  • United States / epidemiology
  • Vaccination / methods

Substances

  • Rabies Vaccines

Grants and funding

The author(s) received no specific funding for this work.